Search for: "Pharmaceutical Associates, Inc." Results 501 - 520 of 1,890
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 May 2012, 7:30 pm by Matthew Bush
In association with Bloomberg Law [read post]
5 Sep 2011, 11:49 pm by Editors
Wang Community Health Center, New York, NYInvestment Adviser (Senior Paralegal or Junior JD) – Investment Management Company and Registered Investment Advisor, Washington, DCEmployment & Labor Law Vice President, Corporate Counsel – Confidential, Newark, NJPatent Counsel, Europe – Global Pharmaceutical Company, United Kingdom (London)Legal Counsel – Confidential, The Woodlands, TXAssistant Counsel – Quidsi Inc., Jersey City, NJAssociate General… [read post]
1 Apr 2014, 7:21 am by Nicolette Koozer
 Elizabeth and Katrina Iserman from Sunovion Pharmaceuticals attending the Democratic Governor’s Association [DGA] reception at Mayflower Hotel during NGA Winter Meeting in Washington, D.C. [read post]
17 Sep 2011, 5:43 am by Jonathan Rosenfeld
The lawsuit alleges that Actos' manufacturer, Takeda Pharmaceuticals North America (and other entities including: Takeda Global Research & Development Center Inc., Takeda Pharmaceuticals Company Ltd., Takeda Pharmaceuticals America, Takeda San Diego Inc., Takeda Pharmaceuticals International Inc and Eli Lilly and Company), was negligent for not providing any warnings regarding the increased bladder cancer risk… [read post]
4 May 2018, 8:34 am by m zamora
From the FDA:Primus Pharmaceuticals, Inc. of Scottsdale, Arizona is voluntarily recalling all unexpired lots of Limbrel products to the patient (user/consumer) level at FDA's request. [read post]
4 Feb 2015, 1:43 pm
These lawsuits also claim that Bayer AG and Janssen Pharmaceuticals Inc., a part of the Johnson & Johnson Company failed to warn doctors and their patients that Xarelto has no antidote to reverse bleeding should significant bleeding events occur in patients. [read post]
25 Jul 2011, 10:48 am by admin
Bisphosphonates for the treatment and prevention of osteoporosis include: FOSAMAX (alendronate sodium) tablets and solution and FOSAMAX PLUS D (alendronate sodium/cholecalciferol) tablets, Merck & Co., Inc.; ACTONEL (risedronate sodium) tablets, ATELVIA (risedronate sodium) delayed release tablets, and ACTONEL WITH CALCIUM (Copackaged) (risedronate sodium with calcium carbonate) tablets, Warner Chilcott, LLC; BONIVA (ibandronate sodium) tablets and injection, Roche Therapeutics,… [read post]
10 Aug 2021, 6:20 am by Robert Kraft
” Additionally, “Pharmacy operators Walgreens Boots Alliance Inc, CVS Health Corp, Rite Aid Corp, and Walmart Inc agreed to settle with the counties for a combined $26 million. [read post]
21 Nov 2011, 11:53 am by Stephen Jenei
Merits Briefs for the Respondent Brief for Prometheus Laboratories Amicus Brief in Support of the Respondent Brief for SAP America, Inc., in Support of Affirming the Federal Circuit’s Opinion Brief for the Pharmaceutical Research and Manufacturers of America Brief for Myriad Genetics, Inc., Brief for the Biotechnology Organization  Brief for the Association of University Technology Managers Brief for the American Intellectual Property Law… [read post]
26 Sep 2017, 2:15 pm by Tom Lamb
19 Patients Have Died While Using This New Liver Disease Drug, Sometimes Prescribed At Higher Doses Than Recommended   (Posted by Tom Lamb at DrugInjuryWatch.com)   Intercept Pharmaceuticals Inc's Ocaliva (obeticholic acid) was approved by the FDA in May 2016 for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as monotherapy in adults unable to tolerate UDCA. [read post]
14 Apr 2014, 3:51 pm by Lyle Denniston
The generic firms — Sandoz Inc., Momenta Pharmaceuticals, Inc., Mylan Pharmaceuticals, Inc., and Natco Pharma Ltd. [read post]
19 Sep 2011, 6:49 am by Darren Tobin
Notwithstanding the serious risk, the manufacturer of ACTOS, Takeda Pharmaceuticals North America Inc., has told reporters that the company remains positive about the drug. [read post]
28 Jul 2023, 11:46 am by Tom Lamb
Today we learned that soon after the July 2023 ASRS letter was sent out, a so-called "Dear Doctor" letter was sent to ophthalmologists by Apellis Pharmaceuticals, Inc., the drug company responsible for Syfovre. [read post]
11 Jul 2012, 10:22 am by Matthew Huisman
Before joining Amgen, Petty was a partner at Ropes & Gay and also served as associate chief counsel for enforcement at the FDA. [read post]